Treating Ulcerative Colitis With Remicade
Links shared publicly online about this topic
FDA approves Remicade to treat ulcerative colitis in children - News
virtualmedicalcentre.com — “The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children 6 years and older who have had inadequate response to conventional therapy.” View full resource at virtualmedicalcentre.com
Most Recently Shared on October 9, 2011 at 2:07 pm By:
VirtualMedicalCentre Health Site
FDA approves Remicade to treat ulcerative colitis in children http://t.co/oERwrjn9 #Healthnews
Ulcerative Colitis
digestive.niddk.nih.gov — “Outlines the symptoms, diagnostic procedures, and risks and benefits of several drugs and kinds of surgery to treat this disease” View full resource at digestive.niddk.nih.gov
Most Recently Shared on January 12, 2010 at 1:50 am By:
Information of Ulcerative Colitis via NDDIC http://tiny.cc/dic51
New Clues for Treating Ulcerative Colitis:
health.msn.com — “New Clues for Treating Ulcerative Colitis:” View full resource at health.msn.com
Most Recently Shared on June 16, 2010 at 9:54 pm By:
New Clues for Treating Ulcerative Colitis: http://bit.ly/cZc2EE
FDA advisers endorse Remicade for children with ulcerative colitis - Related Stories - AANP SmartBrief
smartbrief.com — “The benefit-risk profile of Johnson & Johnson's Remicade supports its approval for treating ulcerative colitis in children for whom other medications don't work, an FDA advisory panel concluded. However, panelists said additional data are warranted on the risk of cancer, particularly hepatosplenic …” View full resource at smartbrief.com
Most Recently Shared on July 22, 2011 at 3:29 pm By:
FDA advisers endorse #Remicade for children with ulcerative colitis http://t.co/9JEEw2D #peds #GI
FDA advisers endorse Remicade for children with ulcerative colitis - Related Stories - AAP SmartBrief
smartbrief.com — “The benefit-risk profile of Johnson & Johnson's Remicade supports its approval for treating ulcerative colitis in children for whom other medications don't work, an FDA advisory panel concluded. However, panelists said additional data are warranted on the risk of cancer, particularly hepatosplenic …” View full resource at smartbrief.com
Most Recently Shared on July 25, 2011 at 3:49 pm By:
Clara Song Pediatrician, Physician, and Doctor
FDA advisers endorse Remicade for children with ulcerative colitis http://t.co/p4G8JU4
New Clues for Treating Ulcerative Colitis
news.healingwell.com — “New Clues for Treating Ulcerative Colitis” View full resource at news.healingwell.com
Most Recently Shared on June 16, 2010 at 9:07 pm By:
New Clues for Treating Ulcerative Colitis news http://bit.ly/cxIZSc #crohns
Which Physicians Treat Ulcerative Colitis?
livingwithuc.com — “Getting proper ulcerative colitis treatment means finding the right physician. Learn which physicians are knowledgeable of UC.” View full resource at livingwithuc.com
Most Recently Shared on April 26, 2010 at 1:21 pm By:
Proper ulcerative colitis treatment means finding the right physician. Learn which physicians are knowledgeable of UC. http://bit.ly/aNNTqE
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - ONA
oncologynurseadvisor.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 10, 2011 at 3:36 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients http://goo.gl/fb/qYVQj
Supplemental BLA submitted for Remicade for pediatric ulcerative colitis - MPR
empr.com — “Centocor Ortho Biotech announced that it submitted a supplemental Biologics License Application (sBLA) to the FDA for Remicade (infliximab) for the treatment of moderately to severely active ulcerative colitis (UC) in pediatric patients who have had an inadequate response to conventional therapy.” View full resource at empr.com
Most Recently Shared on December 29, 2010 at 4:14 pm By:
MPR News: Supplemental BLA submitted for Remicade for pediatric ulcerative colitis: Centocor Ortho Biotech annou... http://bit.ly/erEMRU
Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients - MPR
empr.com — “Centocor Ortho Biotech announced results from its Phase 3 study of Remicade (infliximab) in the treatment of pediatric patients with moderately to severely active ulcerative colitis (UC).” View full resource at empr.com
Most Recently Shared on May 10, 2011 at 3:54 pm By:
MPR News: Phase 3 Study of Remicade for Ulcerative Colitis in Pediatric Patients: Centocor Ortho Biotech announc... http://bit.ly/mK0h6c
Remicade: first biological agent for paediatric ulcerative colitis | MIMS online
mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS online” View full resource at mims.co.uk
Most Recently Shared on May 2, 2012 at 8:57 am By:
Remicade (infliximab): first biological agent licensed for paediatric ulcerative colitis: http://t.co/J4o7OTzh #gastroenterology
Available Ulcerative Colitis Treatments
remicade.com — “A variety of ulcerative colitis treatments are available, including anti-inflammatory medications, immunosuppressive medications, and REMICADE" (infliximab).” View full resource at remicade.com
Most Recently Shared on April 25, 2010 at 3:40 am By:
Susan Scroggins Active Health Library and Health Advocate
There are a variety of treatments available today for ulcerative colitis (UC). Remicade explains the options. http://bit.ly/cn5yC3
REMICADE® Receives FDA Approval As First Biologic Treatment For Pediatric Ulcerative Colitis
medicalnewstoday.com — “Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved REMICADE® (infliximab) for the treatment of moderately to severely active ulcerative colitis” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2011 at 8:05 am By:
Crohn Disease Wisdom OW Health
REMICADE® Receives FDA Approval As First Biologic Treatment For Pediatric Ulcerative Colitis: Janssen Biotech, ... http://t.co/maXFag05
Drug May Help Colitis Patients Avoid Surgery - Drugs.com MedNews
drugs.com — “Treatment with the drug infliximab (Remicade) reduced the need for surgery in ulcerative colitis patients by almost half, a new study found. Ulcerative colitis ” View full resource at drugs.com
Most Recently Shared on October 2, 2009 at 8:25 pm By:
Drug May Help Colitis Patients Avoid Surgery - http://bit.ly/1qV6V3
Treating Crohn's disease - Crohn's & Colitis - Medbroadcast
medbroadcast.com — “inflammatory bowel disease, IBD, Crohn's disease, Crohn's, ulcerative colitis, CD, UC, colitis, biologic response modifier, biologic, 5-ASA, 5-aminosalicylic acid, corticosteroid, corticosteroids” View full resource at medbroadcast.com
Most Recently Shared on July 12, 2010 at 1:48 pm By:
Crohn's disease: What can you expect from treatment? http://bit.ly/dCMBFu
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
VirtualMedicalCentre
Your best resource for healthcare information
-
Teresa Heithaus
Staff Development Instructor. Coordinates hospital web-based education for nurses. Enjoys finding, learning and using new apps
-
msn
Advertisement
